2018
DOI: 10.1177/2045894018762242
|View full text |Cite
|
Sign up to set email alerts
|

Novel imaging approaches for small animal models of lung disease (2017 Grover Conference series)

Abstract: Imaging in small animal models of lung disease is challenging, as existing technologies are limited either by resolution or by the terminal nature of the imaging approach. Here, we describe the current state of small animal lung imaging, the technological advances of laboratory-sourced phase contrast X-ray imaging, and the application of this novel technology and its attendant image analysis techniques to the in vivo imaging of the large airways and pulmonary vasculature in murine models of lung health and dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 75 publications
(94 reference statements)
0
9
0
Order By: Relevance
“…Moreover, animals can be randomized between treatment groups, thus, reducing experimental bias. [47][48][49] In summary, using imaging techniques and analytical methods, we were able to quantify NM-induced pathological alterations over time in live animals and confirm the ability of anti-TNF-α antibody to blunt lung toxicity. These methods can be applied to other animal models to assess lung injury and fibrosis and to enhance the prediction and potential mitigation of injury with therapeutics.…”
Section: Discussionmentioning
confidence: 61%
“…Moreover, animals can be randomized between treatment groups, thus, reducing experimental bias. [47][48][49] In summary, using imaging techniques and analytical methods, we were able to quantify NM-induced pathological alterations over time in live animals and confirm the ability of anti-TNF-α antibody to blunt lung toxicity. These methods can be applied to other animal models to assess lung injury and fibrosis and to enhance the prediction and potential mitigation of injury with therapeutics.…”
Section: Discussionmentioning
confidence: 61%
“…Recent clinical studies have demonstrated that the PBV serves as prognostic marker for diseases affecting the heart and/or lung, in particular chronic heart failure 3 , systemic sclerosis 4 , and acute pulmonary embolism 5 . For preclinical research in cardiac and pulmonary disease mouse models are widely used 6 , 7 , for which PBV may also serve as an interesting parameter. However, non-invasive measurement of PBV in mice appears to be challenging due to the animals’ small size and high heart rate.…”
Section: Introductionmentioning
confidence: 99%
“…Small rodent models have become crucial to the research of lung physiology and pathology (Kiessling et al, ; Pinar and Jones, ). Owing to the importance of the pathologic changes in airflow and lung volumes in disease, there is an interest in assessing these functions in experimental models.…”
Section: Introductionmentioning
confidence: 99%
“…Owing to the importance of the pathologic changes in airflow and lung volumes in disease, there is an interest in assessing these functions in experimental models. Because spirometry and tidal volume techniques provide only summary measurements of the entire lungs, there is continued interest in image‐based techniques for assessing regional lung physiology (Pinar and Jones, ) via assessing the physical properties of the lung microstructure under various imposed conditions. The current reference standard for small animal lung imaging remains computed tomography (micro‐CT) (Clark and Badea, ; Badea, ).…”
Section: Introductionmentioning
confidence: 99%